{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T10:58:53Z","timestamp":1684234733343},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s12282-021-01291-4","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T18:02:36Z","timestamp":1631124156000},"page":"144-155","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["FE65 in breast cancer and its clinicopathological significance"],"prefix":"10.1007","volume":"29","author":[{"given":"Junyao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erina","family":"Iwabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"1291_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2996","author":"C Fitzmaurice","year":"2019","unstructured":"Fitzmaurice C, Abate D, Abbasi N, et al. Global burden of disease cancer. JAMA Oncol. 2019. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2996.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1291_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"1291_CR3","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.1074\/jbc.272.10.6399","volume":"272","author":"N Zambrano","year":"1997","unstructured":"Zambrano N, Buxbaum JD, Minopoli G, et al. Interaction of the phosphotyrosine interaction\/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer\u2019s beta-amyloid precursor proteins. J Biol Chem. 1997;272(10):6399\u2013405. https:\/\/doi.org\/10.1074\/jbc.272.10.6399.","journal-title":"J Biol Chem"},{"issue":"27","key":"1291_CR4","doi-asserted-by":"publisher","first-page":"19119","DOI":"10.1074\/jbc.M801827200","volume":"283","author":"T Nakaya","year":"2008","unstructured":"Nakaya T, Kawai T, Suzuki T. Regulation of FE65 nuclear translocation and function by amyloid beta-protein precursor in osmotically stressed cells. J Biol Chem. 2008;283(27):19119\u201331. https:\/\/doi.org\/10.1074\/jbc.M801827200.","journal-title":"J Biol Chem"},{"issue":"7","key":"1291_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"FM LaFerla","year":"2007","unstructured":"LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer\u2019s disease. Nat Rev Neurosci. 2007;8(7):499\u2013509. https:\/\/doi.org\/10.1038\/nrn2168.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"1291_CR6","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1083\/jcb.153.7.1403","volume":"153","author":"SL Sabo","year":"2001","unstructured":"Sabo SL, Ikin AF, Buxbaum JD, Greengard P. The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement. J Cell Biol. 2001;153(7):1403\u201314. https:\/\/doi.org\/10.1083\/jcb.153.7.1403.","journal-title":"J Cell Biol"},{"key":"1291_CR7","doi-asserted-by":"publisher","first-page":"25652","DOI":"10.1038\/srep25652","volume":"6","author":"P Strecker","year":"2016","unstructured":"Strecker P, Ludewig S, Rust M, et al. FE65 and FE65L1 share common synaptic functions and genetically interact with the APP family in neuromuscular junction formation. Sci Rep. 2016;6:25652. https:\/\/doi.org\/10.1038\/srep25652.","journal-title":"Sci Rep"},{"issue":"5","key":"1291_CR8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/(sici)1097-4547(19991201)58:5<632::aid-jnr4>3.0.co;2-p","volume":"58","author":"Q Hu","year":"1999","unstructured":"Hu Q, Hearn MG, Jin LW, et al. Alternatively spliced isoforms of FE65 serve as neuron-specific and non-neuronal markers. J Neurosci Res. 1999;58(5):632\u201340. https:\/\/doi.org\/10.1002\/(sici)1097-4547(19991201)58:5%3c632::aid-jnr4%3e3.0.co;2-p.","journal-title":"J Neurosci Res"},{"key":"1291_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/353145","volume":"2012","author":"DA Borquez","year":"2012","unstructured":"Borquez DA, Gonzalez-Billault C. The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimer\u2019s disease? Int J Alzheimers Dis. 2012;2012: 353145. https:\/\/doi.org\/10.1155\/2012\/353145.","journal-title":"Int J Alzheimers Dis"},{"issue":"11","key":"1291_CR10","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1128\/mcb.16.11.6229","volume":"16","author":"JP Borg","year":"1996","unstructured":"Borg JP, Ooi J, Levy E, Margolis B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol. 1996;16(11):6229\u201341. https:\/\/doi.org\/10.1128\/mcb.16.11.6229.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"1291_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jnr.21532","volume":"86","author":"DM McLoughlin","year":"2008","unstructured":"McLoughlin DM, Miller CC. The FE65 proteins and Alzheimer\u2019s disease. J Neurosci Res. 2008;86(4):744\u201354. https:\/\/doi.org\/10.1002\/jnr.21532.","journal-title":"J Neurosci Res"},{"issue":"3","key":"1291_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1046\/j.1471-4159.1999.0730985.x","volume":"73","author":"SY Guenette","year":"1999","unstructured":"Guenette SY, Chen J, Ferland A, et al. hFE65L influences amyloid precursor protein maturation and secretion. J Neurochem. 1999;73(3):985\u201393. https:\/\/doi.org\/10.1046\/j.1471-4159.1999.0730985.x.","journal-title":"J Neurochem"},{"issue":"12","key":"1291_CR13","doi-asserted-by":"publisher","first-page":"7952","DOI":"10.1074\/jbc.274.12.7952","volume":"274","author":"SL Sabo","year":"1999","unstructured":"Sabo SL, Lanier LM, Ikin AF, et al. Regulation of beta-amyloid secretion by FE65, an amyloid protein precursor-binding protein. J Biol Chem. 1999;274(12):7952\u20137. https:\/\/doi.org\/10.1074\/jbc.274.12.7952.","journal-title":"J Biol Chem"},{"key":"1291_CR14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7103","author":"P Pandey","year":"2016","unstructured":"Pandey P, Sliker B, Peters HL, et al. Amyloid precursor protein and amyloid precursor like protein 2 in cancer. Oncotarget. 2016. https:\/\/doi.org\/10.18632\/oncotarget.7103.","journal-title":"Oncotarget"},{"issue":"11","key":"1291_CR15","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1634\/theoncologist.2018-0012","volume":"23","author":"JYS Tsang","year":"2018","unstructured":"Tsang JYS, Lee MA, Ni YB, et al. Amyloid precursor protein is associated with aggressive behavior in nonluminal breast cancers. Oncologist. 2018;23(11):1273\u201381. https:\/\/doi.org\/10.1634\/theoncologist.2018-0012.","journal-title":"Oncologist"},{"issue":"11","key":"1291_CR16","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/cas.12239","volume":"104","author":"K Takagi","year":"2013","unstructured":"Takagi K, Ito S, Miyazaki T, et al. Amyloid precursor protein in human breast cancer: an androgen-induced gene associated with cell proliferation. Cancer Sci. 2013;104(11):1532\u20138. https:\/\/doi.org\/10.1111\/cas.12239.","journal-title":"Cancer Sci"},{"issue":"8","key":"1291_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152463","volume":"215","author":"S Ito","year":"2019","unstructured":"Ito S, Miki Y, Saito R, et al. Amyloid precursor protein and its phosphorylated form in non-small cell lung carcinoma. Pathol Res Pract. 2019;215(8): 152463. https:\/\/doi.org\/10.1016\/j.prp.2019.152463.","journal-title":"Pathol Res Pract"},{"key":"1291_CR18","doi-asserted-by":"publisher","first-page":"11529","DOI":"10.1038\/srep11529","volume":"5","author":"Y Sun","year":"2015","unstructured":"Sun Y, Sun J, Lungchukiet P, et al. Fe65 suppresses breast cancer cell migration and invasion through Tip60 mediated cortactin acetylation. Sci Rep. 2015;5:11529. https:\/\/doi.org\/10.1038\/srep11529.","journal-title":"Sci Rep"},{"issue":"12","key":"1291_CR19","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/iub.1094","volume":"64","author":"G Minopoli","year":"2012","unstructured":"Minopoli G, Gargiulo A, Parisi S, et al. Fe65 matters: new light on an old molecule. IUBMB Life. 2012;64(12):936\u201342. https:\/\/doi.org\/10.1002\/iub.1094.","journal-title":"IUBMB Life"},{"issue":"18","key":"1291_CR20","doi-asserted-by":"publisher","first-page":"12217","DOI":"10.1074\/jbc.M113.526194","volume":"289","author":"Y Sun","year":"2014","unstructured":"Sun Y, Kasiappan R, Tang J, et al. A novel function of the Fe65 neuronal adaptor in estrogen receptor action in breast cancer cells. J Biol Chem. 2014;289(18):12217\u201331. https:\/\/doi.org\/10.1074\/jbc.M113.526194.","journal-title":"J Biol Chem"},{"issue":"7615","key":"1291_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature19076","volume":"536","author":"B Strilic","year":"2016","unstructured":"Strilic B, Yang L, Albarran-Juarez J, et al. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis. Nature. 2016;536(7615):215\u20138. https:\/\/doi.org\/10.1038\/nature19076.","journal-title":"Nature"},{"issue":"2","key":"1291_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s13277-012-0589-7","volume":"34","author":"L Jiang","year":"2013","unstructured":"Jiang L, Yu G, Meng W, et al. Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2. Tumour Biol. 2013;34(2):629\u201336. https:\/\/doi.org\/10.1007\/s13277-012-0589-7.","journal-title":"Tumour Biol"},{"key":"1291_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ebiom.2018.11.012","volume":"38","author":"JYS Tsang","year":"2018","unstructured":"Tsang JYS, Lee MA, Chan TH, et al. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer. EBioMedicine. 2018;38:89\u201399. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.012.","journal-title":"EBioMedicine"},{"key":"1291_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2014.06.010","author":"C Shi","year":"2014","unstructured":"Shi C, Zhu X, Wang J, et al. Estrogen receptor alpha promotes non-amyloidogenic processing of platelet amyloid precursor protein via the MAPK\/ERK pathway. J Steroid Biochem Mol Biol. 2014. https:\/\/doi.org\/10.1016\/j.jsbmb.2014.06.010.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1291_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3892\/ijmm.2019.4404","volume":"45","author":"X Wu","year":"2020","unstructured":"Wu X, Chen S, Lu C. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway. Int J Mol Med. 2020;45(1):162\u201374. https:\/\/doi.org\/10.3892\/ijmm.2019.4404.","journal-title":"Int J Mol Med"},{"issue":"5","key":"1291_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139(5):871\u201390. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007.","journal-title":"Cell"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-021-01291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-021-01291-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-021-01291-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T19:02:48Z","timestamp":1641409368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-021-01291-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1007\/s12282-021-01291-4","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"20 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared that they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}